BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 11560978)

  • 21. Chemoprevention of lung cancer.
    Cohen V; Khuri FR
    Curr Opin Pulm Med; 2004 Jul; 10(4):279-83. PubMed ID: 15220752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoprevention of lung cancer: current status and future prospects.
    Cohen V; Khuri FR
    Cancer Metastasis Rev; 2002; 21(3-4):349-62. PubMed ID: 12549771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methods and strategies in lung cancer control.
    Castonguay A
    Cancer Res; 1992 May; 52(9 Suppl):2641s-2651s. PubMed ID: 1562994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in the biology of lung cancer chemoprevention.
    Hirsch FR; Lippman SM
    J Clin Oncol; 2005 May; 23(14):3186-97. PubMed ID: 15886305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.
    Khuri FR; Lee JJ; Lippman SM; Kim ES; Cooper JS; Benner SE; Winn R; Pajak TF; Williams B; Shenouda G; Hodson I; Fu K; Shin DM; Vokes EE; Feng L; Goepfert H; Hong WK
    J Natl Cancer Inst; 2006 Apr; 98(7):441-50. PubMed ID: 16595780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-carotene in multivitamins and the possible risk of lung cancer among smokers versus former smokers: a meta-analysis and evaluation of national brands.
    Tanvetyanon T; Bepler G
    Cancer; 2008 Jul; 113(1):150-7. PubMed ID: 18429004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chemoprevention of bronchogenic carcinoma].
    Votruba J; St'astný B
    Cas Lek Cesk; 2000 Nov; 139(22):702-4. PubMed ID: 11191751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemoprevention of lung cancer: the rise and demise of beta-carotene.
    Omenn GS
    Annu Rev Public Health; 1998; 19():73-99. PubMed ID: 9611613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Chemoprevention of tobacco-related lung cancer by cruciferous vegetable].
    Balcerek M
    Przegl Lek; 2007; 64(10):903-5. PubMed ID: 18409338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic susceptibility to lung cancer: implications for smoking cessation.
    Houfek JF; Atwood JR
    Medsurg Nurs; 2003 Feb; 12(1):45-9. PubMed ID: 12619599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemoprevention trials in the cervix: design, feasibility, and recruitment.
    Mitchell MF; Hittelman WN; Lotan R; Nishioka K; Tortolero-Luna G; Richards-Kortum R; Hong WK
    J Cell Biochem Suppl; 1995; 23():104-12. PubMed ID: 8747384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cigarettes: a smoking gun in cancer chemoprevention.
    Mayne ST; Lippman SM
    J Natl Cancer Inst; 2005 Sep; 97(18):1319-21. PubMed ID: 16174848
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevention of lung cancer. The new millennium.
    Kim ES; Hong WK; Khuri FR
    Chest Surg Clin N Am; 2000 Nov; 10(4):663-90, v. PubMed ID: 11091919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smokers and urinary genotoxins: implications for selection of cohorts and modulation of endpoints in chemoprevention trials.
    De Flora S; Camoirano A; Bagnasco M; Bennicelli C; van Zandwijk N; Wigbout G; Qian GS; Zhu YR; Kensler TW
    J Cell Biochem Suppl; 1996; 25():92-8. PubMed ID: 9027604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of chemoprevention in cancer control.
    Greenwald P; Kelloff GJ
    IARC Sci Publ; 1996; (139):13-22. PubMed ID: 8923016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carcinogen biomarkers for lung or oral cancer chemoprevention trials.
    Hecht SS
    IARC Sci Publ; 2001; 154():245-55. PubMed ID: 11220664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort.
    Spitz MR; Barnett MJ; Goodman GE; Thornquist MD; Wu X; Pollak M
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1413-8. PubMed ID: 12433720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung cancer chemoprevention.
    Khuri FR; Lippman SM
    Semin Surg Oncol; 2000 Mar; 18(2):100-5. PubMed ID: 10657911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Individual susceptibility to occupational carcinogens: the evidence from biomonitoring and molecular epidemiology studies].
    Pavanello S; Clonfero E
    G Ital Med Lav Ergon; 2004; 26(4):311-21. PubMed ID: 15584438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemoprevention strategies for prostate cancer.
    Bosland MC; McCormick DL; Melamed J; Walden PD; Zeleniuch-Jacquotte A; Lumey LH
    Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S18-27. PubMed ID: 12570331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.